Why do we not have an HIV vaccine and how can we make one?

This publication has 28 references indexed in Scilit:

• Vigorous HIV-1-Specific CD4 ⁺ T Cell Responses Associated with Control of Viremia
  Science, 1997
• HIV versus Cytotoxic T Lymphocytes — The War Being Lost
  New England Journal of Medicine, 1997
• A vaccine for HIV type 1: The antibody perspective
  Proceedings of the National Academy of Sciences, 1997
• HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication
  Springer Seminars in Immunopathology, 1997
• Immunity to retroviral infection: The Friend virus model
  Proceedings of the National Academy of Sciences, 1997
• A critical role for neutralizing-antibody-producing B cells, CD4⁺T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers
  Proceedings of the National Academy of Sciences, 1997
• Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
  Nature Medicine, 1997
• Strategies for AIDS vaccines
  Journal of Antimicrobial Chemotherapy, 1996
• Immune responses in HIV-exposed seronegatives: have they repelled the virus?
  Current Opinion in Immunology, 1995
• The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-α
  AIDS, 1995